Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
A Manual for Nations to Head out To- India’s delayed climate plan sets modest emission target
- AbbVie plans to build out its presence in obesity market
- Elite Execution Gaming PCs for Gamers
- The Best Business visionaries Under 30
- Illegal entries into Germany halve over two years, border police say
- An Excursion Through Renowned Western Network programs
- Merz says army could be involved in mine-clearing from Hormuz
- Bayer reports positive results for blood thinner after 2023 setback
